Literature DB >> 9644262

Evidence for chloramphenicol/H+ antiport in Cmr (MdfA) system of Escherichia coli and properties of the antiporter.

T Mine1, Y Morita, A Kataoka, T Mizushima, T Tsuchiya.   

Abstract

We detected chloramphenicol/H+ antiport activity in membrane vesicles of Escherichia coli and cloned a gene for the antiporter from chromosomal DNA of E. coli. Introduction of the gene into E. coli cells conferred resistance to chloramphenicol and ethidium. A slight increase in resistance to acridine orange was also observed. Elevated chloramphenicol efflux and ethidium efflux were observed in cells harboring a plasmid carrying the gene. Addition of chloramphenicol to the assay mixture reduced the efflux of ethidium. Elevated chloramphenicol/H+ antiport activity was observed in membrane vesicles prepared from cells harboring the plasmid. The pH optimum for the activity was 6.5. We sequenced the gene and deduced the amino acid sequence of its product. A sequence homology search revealed that it was same as that of Cmr (or MdfA). Thus, it became clear that Cmr (MdfA) is the chloramphenicol(and ethidium)/H+ antiporter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9644262     DOI: 10.1093/oxfordjournals.jbchem.a022078

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  24 in total

1.  Membrane topology of the multidrug transporter MdfA: complementary gene fusion studies reveal a nonessential C-terminal domain.

Authors:  Julia Adler; Eitan Bibi
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

2.  The Escherichia coli multidrug transporter MdfA catalyzes both electrogenic and electroneutral transport reactions.

Authors:  Oded Lewinson; Julia Adler; Gerrit J Poelarends; Piotr Mazurkiewicz; Arnold J M Driessen; Eitan Bibi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

3.  AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters.

Authors:  Xian-Zhong Su; Jing Chen; Tohru Mizushima; Teruo Kuroda; Tomofusa Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  No single irreplaceable acidic residues in the Escherichia coli secondary multidrug transporter MdfA.

Authors:  Nadejda Sigal; Shahar Molshanski-Mor; Eitan Bibi
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

5.  The secondary multidrug/proton antiporter MdfA tolerates displacements of an essential negatively charged side chain.

Authors:  Nadejda Sigal; Nir Fluman; Shira Siemion; Eitan Bibi
Journal:  J Biol Chem       Date:  2009-01-07       Impact factor: 5.157

6.  Manipulating the drug/proton antiport stoichiometry of the secondary multidrug transporter MdfA.

Authors:  Osnat Tirosh; Nadejda Sigal; Amir Gelman; Nadav Sahar; Nir Fluman; Shira Siemion; Eitan Bibi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

7.  SugE, a new member of the SMR family of transporters, contributes to antimicrobial resistance in Enterobacter cloacae.

Authors:  Gui-Xin He; Chu Zhang; Robert R Crow; Conner Thorpe; Huizhong Chen; Sanath Kumar; Tomofusa Tsuchiya; Manuel F Varela
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

8.  smFRET Probing Reveals Substrate-Dependent Conformational Dynamics of E. coli Multidrug MdfA.

Authors:  Yongping Zhu; Lingli He; Yue Liu; Yongfang Zhao; Xuejun C Zhang
Journal:  Biophys J       Date:  2019-05-07       Impact factor: 4.033

9.  An H(+)-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa.

Authors:  Gui-Xin He; Teruo Kuroda; Takehiko Mima; Yuji Morita; Tohru Mizushima; Tomofusa Tsuchiya
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

10.  Identification, cloning, and functional characterization of EmrD-3, a putative multidrug efflux pump of the major facilitator superfamily from Vibrio cholerae O395.

Authors:  Kenneth P Smith; Sanath Kumar; Manuel F Varela
Journal:  Arch Microbiol       Date:  2009-10-30       Impact factor: 2.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.